In June 2022, the members of the European Alliance for Responsible R&D and Affordable Medicines gathered in Rome to analyse the current public health scene and discuss potential solutions to the most prominent challenges. In light of public health outbreaks in the...
As the COVID pandemic started, expectations in the “access to medicines” community raised. After all, if a pandemic could not build the case for equitable access to vaccines and medicines, what would? Yet, initial promises, such as Von der Leyen’s commitment to...
It is undeniable that COVID-19 put a lot of pressure on the entire international health system, bringing the workload and intensity of care professionals to the extreme. Although the situation improved a lot over the last months, we cannot let our guard down and we...
For the first time since the COVID-19 pandemic began, health ministers and high-level delegates of the 53 Member States of the WHO European Region, as well as representatives of partner organizations and civil society, gathered in September in Tel Aviv for the 72nd...
Rosa Castro of the European Public Health Alliance argues for an alternative to a transferable exclusivity extension to address the lack of new antibiotics. READ THE...